A detailed history of Armstrong Advisory Group, Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 500 shares of ZTS stock, worth $88,480. This represents 0.01% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$88,480
Previous $86,000 12.79%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$145.54 - $178.83 $9,896 - $12,160
-68 Reduced 11.97%
500 $86,000
Q4 2022

Jan 17, 2023

BUY
$131.14 - $157.47 $74,487 - $89,442
568 New
568 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Armstrong Advisory Group, Inc Portfolio

Follow Armstrong Advisory Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Advisory Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Advisory Group, Inc with notifications on news.